Vitura Health Ltd (AU:VIT) — Market Cap & Net Worth
Market Cap & Net Worth: Vitura Health Ltd (VIT)
Vitura Health Ltd (AU:VIT) has a market capitalization of $13.60 Million (AU$19.22 Million) as of June 20, 2026. Listed on the AU stock exchange, this Australia-based company holds position #26265 globally and #1208 in its home market, demonstrating a 3.57% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vitura Health Ltd's stock price AU$0.03 by its total outstanding shares 662741837 (662.74 Million). Review debt load of Vitura Health Ltd to assess the company's total debt and financial obligations.
Vitura Health Ltd Market Cap History: 2019 to 2026
Vitura Health Ltd's market capitalization history from 2019 to 2026. Data shows change from $89.80 Million to $13.60 Million (-30.60% CAGR).
Vitura Health Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vitura Health Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.23x
Vitura Health Ltd's market cap is 0.23 times its annual revenue
Latest Price to Earnings (P/E) Ratio
8.60x
Vitura Health Ltd's market cap is 8.60 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $58.34 Million | $123.85K | -$3.94 Million | 471.01x | N/A |
| 2021 | $89.80 Million | $21.71 Million | -$4.05 Million | 4.14x | N/A |
| 2022 | $266.92 Million | $66.99 Million | $6.05 Million | 3.98x | 44.13x |
| 2023 | $119.58 Million | $117.34 Million | $13.81 Million | 1.02x | 8.66x |
| 2024 | $38.45 Million | $123.87 Million | $3.51 Million | 0.31x | 10.95x |
| 2025 | $28.60 Million | $124.04 Million | $3.32 Million | 0.23x | 8.60x |
Competitor Companies of VIT by Market Capitalization
Companies near Vitura Health Ltd in the global market cap rankings as of June 20, 2026.
Key companies related to Vitura Health Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #554 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #602 globally with a market cap of $45.20 Billion USD ( CN¥308.87 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #627 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #515 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #554 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.94 |
| #602 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.20 Billion | CN¥48.42 |
| #627 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.50 |
Vitura Health Ltd Historical Marketcap From 2019 to 2026
Between 2019 and today, Vitura Health Ltd's market cap moved from $89.80 Million to $ 13.60 Million, with a yearly change of -30.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$13.60 Million | -52.46% |
| 2025 | AU$28.60 Million | -25.61% |
| 2024 | AU$38.45 Million | -67.84% |
| 2023 | AU$119.58 Million | -55.20% |
| 2022 | AU$266.92 Million | +197.23% |
| 2021 | AU$89.80 Million | +53.94% |
| 2020 | AU$58.34 Million | -35.04% |
| 2019 | AU$89.80 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 20th, 2026 the market cap of Vitura Health Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.60 Million USD |
| MoneyControl | $13.60 Million USD |
| MarketWatch | $13.60 Million USD |
| marketcap.company | $13.60 Million USD |
| Reuters | $13.60 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vitura Health Ltd
Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia. It operates through two segments: Sales and Distribution; and Clinics and Services. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for alternative therapies; Doctors on Demand, a premier provider of on-demand virtual h… Read more